IP Address: City of Hope Investigational Drug Services(IDS) — Duarte, California

IP Address: City of Hope Investigational Drug Services(IDS) is a clinical research site located in Duarte, California, United States 91010.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

IP Address: City of Hope Investigational Drug Services(IDS) has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Basilea Pharmaceutica.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Duarte

Browse all research sites in California · View every site in Duarte

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IP Address: City of Hope Investigational Drug Services(IDS)?

IP Address: City of Hope Investigational Drug Services(IDS) has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IP Address: City of Hope Investigational Drug Services(IDS) conducted?

IP Address: City of Hope Investigational Drug Services(IDS) has 4 clinical trials on record, with 2 currently active. Their work covers Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse.

Is IP Address: City of Hope Investigational Drug Services(IDS) accredited by Crixeo Clinical Trials?

IP Address: City of Hope Investigational Drug Services(IDS) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about IP Address: City of Hope Investigational Drug Services(IDS)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.